Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

IL-37 is increased in brains of children with autism spectrum disorder and inhibits human microglia stimulated by neurotensin.

Tsilioni I, Patel AB, Pantazopoulos H, Berretta S, Conti P, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21659-21665. doi: 10.1073/pnas.1906817116. Epub 2019 Oct 7.

PMID:
31591201
2.

Increased Expression of miR-155p5 in Amygdala of Children With Autism Spectrum Disorder.

Almehmadi KA, Tsilioni I, Theoharides TC.

Autism Res. 2019 Sep 10. doi: 10.1002/aur.2205. [Epub ahead of print]

PMID:
31502418
3.

Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome.

Theoharides TC, Tsilioni I, Bawazeer M.

Front Cell Neurosci. 2019 Aug 2;13:353. doi: 10.3389/fncel.2019.00353. eCollection 2019. Review.

4.

Mast Cells May Regulate The Anti-Inflammatory Activity of IL-37.

Theoharides TC, Tsilioni I, Conti P.

Int J Mol Sci. 2019 Jul 29;20(15). pii: E3701. doi: 10.3390/ijms20153701.

5.

Mast Cells, Stress, Fear and Autism Spectrum Disorder.

Theoharides TC, Kavalioti M, Tsilioni I.

Int J Mol Sci. 2019 Jul 24;20(15). pii: E3611. doi: 10.3390/ijms20153611. Review.

6.

Effects of an Extract of Salmon Milt on Symptoms and Serum TNF and Substance P in Patients With Fibromyalgia Syndrome.

Tsilioni I, Pipis H, Freitag MSC, Izquierdo MDC, Freitag K, Theoharides TC.

Clin Ther. 2019 Aug;41(8):1564-1574.e2. doi: 10.1016/j.clinthera.2019.05.019. Epub 2019 Jul 11.

PMID:
31303280
7.

The mast cell - neurofibromatosis connection.

Antonopoulos D, Tsilioni I, Balatsos NAA, Gourgoulianis KI, Theoharides TC.

J Biol Regul Homeost Agents. 2019 May-Jun,;33(3):657-659.

PMID:
31184097
8.

Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Theoharides TC, Tsilioni I, Ren H.

Expert Rev Clin Immunol. 2019 Jun;15(6):639-656. doi: 10.1080/1744666X.2019.1596800. Epub 2019 Apr 22.

PMID:
30884251
9.

Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases.

Theoharides TC, Tsilioni I.

Curr Top Med Chem. 2018;18(21):1872-1882. doi: 10.2174/1568026617666181119154247. Review.

PMID:
30451113
10.

Mitochondrial dysfunction in affected skin and increased mitochondrial DNA in serum from patients with psoriasis.

Therianou A, Vasiadi M, Delivanis DA, Petrakopoulou T, Katsarou-Katsari A, Antoniou C, Stratigos A, Tsilioni I, Katsambas A, Rigopoulos D, Theoharides TC.

Exp Dermatol. 2019 Jan;28(1):72-75. doi: 10.1111/exd.13831.

PMID:
30390357
11.

Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin.

Taracanova A, Tsilioni I, Conti P, Norwitz ER, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9381-E9390. doi: 10.1073/pnas.1810133115. Epub 2018 Sep 19.

12.
13.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?

Hatziagelaki E, Adamaki M, Tsilioni I, Dimitriadis G, Theoharides TC.

J Pharmacol Exp Ther. 2018 Oct;367(1):155-167. doi: 10.1124/jpet.118.250845. Epub 2018 Aug 3. Review.

PMID:
30076265
14.

Time to look past TNF and thalidomide for cachexia - could mast cells and flavonoids be the answer?

King L, Tsilioni I, Theoharides TC.

J Biol Regul Homeost Agents. 2018 May-Jun;32(3):443-447.

PMID:
29921368
15.

Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes.

Ratnaseelan AM, Tsilioni I, Theoharides TC.

Clin Ther. 2018 Jun;40(6):903-917. doi: 10.1016/j.clinthera.2018.05.004. Epub 2018 Jun 5. Review.

PMID:
29880330
16.

Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Petra AI, Tsilioni I, Taracanova A, Katsarou-Katsari A, Theoharides TC.

Allergy Asthma Proc. 2018 Mar 1;39(2):153-160. doi: 10.2500/aap.2018.38.4105.

17.

Reply to Fattori et al.: Action of SP and IL-33 on mast cells.

Theoharides TC, Taracanova A, Tsilioni I, Conti P, Leeman SE.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10036. doi: 10.1073/pnas.1716233114. Epub 2017 Nov 6. No abstract available.

18.

TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin.

Patel AB, Tsilioni I, Weng Z, Theoharides TC.

Exp Dermatol. 2018 Feb;27(2):135-143. doi: 10.1111/exd.13461. Epub 2018 Jan 3.

PMID:
29105195
19.

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study.

Palli E, Makris D, Papanikolaou J, Garoufalis G, Tsilioni I, Zygoulis P, Zakynthinos E.

Crit Care. 2017 Oct 31;21(1):269. doi: 10.1186/s13054-017-1862-3.

20.

Tolerability and benefit of a tetramethoxyluteolin-containing skin lotion.

Theoharides TC, Stewart JM, Tsilioni I.

Int J Immunopathol Pharmacol. 2017 Jun;30(2):146-151. doi: 10.1177/0394632017707610. Epub 2017 May 8.

21.

Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism.

Patel AB, Tsilioni I, Leeman SE, Theoharides TC.

Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E7049-E7058. doi: 10.1073/pnas.1604992113. Epub 2016 Sep 23. Erratum in: Proc Natl Acad Sci U S A. 2016 Nov 1;:.

22.

Clinical Significance of Circulating Osteopontin Levels in Patients With Lung Cancer and Correlation With VEGF and MMP-9.

Kerenidi T, Kazakou AP, Lada M, Tsilioni I, Daniil Z, Gourgoulianis KI.

Cancer Invest. 2016 Sep 13;34(8):385-92. doi: 10.1080/07357907.2016.1223301. Epub 2016 Sep 13.

PMID:
27624849
23.

Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders.

Theoharides TC, Tsilioni I, Patel AB, Doyle R.

Transl Psychiatry. 2016 Jun 28;6(6):e844. doi: 10.1038/tp.2016.77. Review.

24.

Nanotube Formation: A Rapid Form of "Alarm Signaling"?

Weng Z, Zhang B, Tsilioni I, Theoharides TC.

Clin Ther. 2016 May;38(5):1066-72. doi: 10.1016/j.clinthera.2016.02.030. Epub 2016 Apr 13.

PMID:
27085584
25.

Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.

Tsilioni I, Filippidis AS, Kerenidi T, Budanov AV, Zarogiannis SG, Gourgoulianis KI.

Clin Biochem. 2016 Jun;49(9):726-728. doi: 10.1016/j.clinbiochem.2016.02.002. Epub 2016 Feb 11.

PMID:
26874199
26.

Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Tsilioni I, Russell IJ, Stewart JM, Gleason RM, Theoharides TC.

J Pharmacol Exp Ther. 2016 Mar;356(3):664-72. doi: 10.1124/jpet.115.230060. Epub 2016 Jan 13.

27.

Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6.

Tsilioni I, Taliou A, Francis K, Theoharides TC.

Transl Psychiatry. 2015 Sep 29;5:e647. doi: 10.1038/tp.2015.142.

28.

Fibromyalgia syndrome in need of effective treatments.

Theoharides TC, Tsilioni I, Arbetman L, Panagiotidou S, Stewart JM, Gleason RM, Russell IJ.

J Pharmacol Exp Ther. 2015 Nov;355(2):255-63. doi: 10.1124/jpet.115.227298. Epub 2015 Aug 25. Review.

29.

Pleural effusion levels of DJ-1 are increased in elderly lung cancer patients with malignant pleural effusions.

Vavougios G, Kerenidi T, Tsilioni I, Zarogiannis SG, Gourgoulianis KI.

Redox Rep. 2015;20(6):254-8. doi: 10.1179/1351000215Y.0000000023. Epub 2015 Jun 30.

PMID:
26125099
30.

Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence.

Skouras VS, Magkouta SF, Psallidas I, Tsilioni I, Maragozidis P, Gourgoulianis KI, Kalomenidis I.

Infect Dis (Lond). 2015 Jul;47(7):477-83. doi: 10.3109/23744235.2015.1019919. Epub 2015 Mar 10.

PMID:
25753767
31.

Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study.

Dimoulis A, Pastaka C, Tsolaki V, Tsilioni I, Pournaras S, Liakos N, Georgoulias P, Gourgoulianis K.

COPD. 2015 Aug;12(4):427-34. doi: 10.3109/15412555.2014.974738.

PMID:
25415619
32.

Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism.

Tsilioni I, Dodman N, Petra AI, Taliou A, Francis K, Moon-Fanelli A, Shuster L, Theoharides TC.

Transl Psychiatry. 2014 Oct 14;4:e466. doi: 10.1038/tp.2014.106.

33.

High serum corticotropin-releasing hormone (CRH) and bone marrow mast cell CRH receptor expression in a mastocytosis patient.

Theoharides TC, Petra AI, Stewart JM, Tsilioni I, Panagiotidou S, Akin C.

J Allergy Clin Immunol. 2014 Nov;134(5):1197-9. doi: 10.1016/j.jaci.2014.05.023. Epub 2014 Jun 27. No abstract available.

PMID:
24985398
34.

Exosomes in neurologic and psychiatric disorders.

Tsilioni I, Panagiotidou S, Theoharides TC.

Clin Ther. 2014 Jun 1;36(6):882-8. doi: 10.1016/j.clinthera.2014.05.005. Epub 2014 Jun 7. Review.

PMID:
24913029
35.

The DJ-1 protein as a candidate biomarker in obstructive sleep apnea syndrome.

Vavougios G, Pastaka C, Tsilioni I, Natsios G, Seitanidis G, Florou E, Gourgoulianis KI.

Sleep Breath. 2014 Dec;18(4):897-900. doi: 10.1007/s11325-014-0952-6. Epub 2014 Feb 15.

PMID:
24532146
36.

Obstructive sleep apnea, excessive daytime sleepiness, and morning plasma TNF-α levels in Greek children.

Alexopoulos EI, Theologi V, Malakasioti G, Maragozidis P, Tsilioni I, Chrousos G, Gourgoulianis K, Kaditis AG.

Sleep. 2013 Nov 1;36(11):1633-8. doi: 10.5665/sleep.3114.

37.

8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.

Malli F, Bardaka F, Tsilioni I, Karetsi E, Gourgoulianis KI, Daniil Z.

Food Chem Toxicol. 2013 Nov;61:160-3. doi: 10.1016/j.fct.2013.05.016. Epub 2013 May 20.

PMID:
23702326
38.

Matrix metaloproteinase-2 and -9 serum levels as potential markers of intraperitoneal adhesions.

Christodoulidis G, Tsilioni I, Spyridakis ME, Kiropoulos T, Oikonomidi S, Koukoulis G, Tepetes K.

J Invest Surg. 2013 Jun;26(3):134-40. doi: 10.3109/08941939.2012.730599. Epub 2013 Mar 20.

PMID:
23514055
39.

Endothelial progenitor cells in the pathogenesis of idiopathic pulmonary fibrosis: an evolving concept.

Malli F, Koutsokera A, Paraskeva E, Zakynthinos E, Papagianni M, Makris D, Tsilioni I, Molyvdas PA, Gourgoulianis KI, Daniil Z.

PLoS One. 2013;8(1):e53658. doi: 10.1371/journal.pone.0053658. Epub 2013 Jan 14.

40.

Pleural fluid protein is inversely correlated with age in uncomplicated parapneumonic pleural effusions.

Zarogiannis SG, Tsilioni I, Hatzoglou C, Molyvdas PA, Gourgoulianis KI.

Clin Biochem. 2013 Mar;46(4-5):378-80. doi: 10.1016/j.clinbiochem.2012.11.024. Epub 2012 Dec 4.

PMID:
23219739
41.

Oxidative stress in patients with obstructive sleep apnea syndrome.

Ntalapascha M, Makris D, Kyparos A, Tsilioni I, Kostikas K, Gourgoulianis K, Kouretas D, Zakynthinos E.

Sleep Breath. 2013 May;17(2):549-55. doi: 10.1007/s11325-012-0718-y. Epub 2012 May 18.

PMID:
22610662
42.

Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions.

Zaga T, Makris D, Tsilioni I, Kiropoulos T, Oikonomidi S, Damianos A, Gourgoulianis KI.

Monaldi Arch Chest Dis. 2011 Sep;75(3):167-71.

43.

Pleural transport physiology: insights from biological marker measurements in transudates.

Apostolidou E, Tsilioni I, Hatzoglou C, Molyvdas PA, Gourgoulianis KI.

Open Respir Med J. 2011;5:70-2. doi: 10.2174/1874306401105010070. Epub 2011 Oct 18.

44.

Serum amyloid alpha in parapneumonic effusions.

Boultadakis V, Skouras V, Makris D, Damianaki A, Nikoulis DJ, Kiropoulos T, Oikonomidi S, Tsilioni I, Gourgoulianis K.

Mediators Inflamm. 2011;2011:237638. doi: 10.1155/2011/237638. Epub 2011 Aug 25.

45.

Diagnostic accuracy of biomarkers of oxidative stress in parapneumonic pleural effusions.

Tsilioni I, Kostikas K, Kalomenidis I, Oikonomidi S, Tsolaki V, Minas M, Gourgoulianis KI, Kiropoulos TS.

Eur J Clin Invest. 2011 Apr;41(4):349-56. doi: 10.1111/j.1365-2362.2010.02413.x. Epub 2010 Dec 1.

PMID:
21121911
46.

Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.

Oikonomidi S, Kostikas K, Kalomenidis I, Tsilioni I, Daenas C, Gourgoulianis KI, Kiropoulos TS.

Respiration. 2010;80(4):285-91. doi: 10.1159/000314586. Epub 2010 May 6.

47.

Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions.

Papaioannou AI, Kostikas K, Tsopa P, Kiropoulos T, Tsilioni I, Oikonomidi S, Gerogianni I, Gourgoulianis KI.

Respiration. 2010;80(6):472-9. doi: 10.1159/000270913. Epub 2009 Dec 21.

48.

The acute effect of smoking in healthy and asthmatic smokers.

Papaioannou AI, Koutsokera A, Tanou K, Kiropoulos TS, Tsilioni I, Oikonomidi S, Liadaki K, Pournaras S, Gourgoulianis KI, Kostikas K.

Eur J Clin Invest. 2010 Feb;40(2):103-9. doi: 10.1111/j.1365-2362.2009.02221.x. Epub 2009 Nov 12.

PMID:
19912318
49.

Systemic and airway inflammation and the presence of emphysema in patients with COPD.

Papaioannou AI, Mazioti A, Kiropoulos T, Tsilioni I, Koutsokera A, Tanou K, Nikoulis DJ, Georgoulias P, Zakynthinos E, Gourgoulianis KI, Kostikas K.

Respir Med. 2010 Feb;104(2):275-82. doi: 10.1016/j.rmed.2009.09.016. Epub 2009 Oct 24.

50.

Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications.

Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, Kiropoulos TS.

Curr Med Chem. 2009;16(10):1214-28. Review.

PMID:
19355880

Supplemental Content

Loading ...
Support Center